The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Amgen; Bayer; Lilly; Roche; Sanofi
First-line FOLFOX plus panitumumab (Pan) followed by 5FU/LV plus Pan or single-agent Pan as maintenance therapy in patients with RAS wild-type metastatic colorectal cancer (mCRC): The VALENTINO study.
 
Filippo Pietrantonio
No Relationships to Disclose
 
Federica Morano
No Relationships to Disclose
 
Salvatore Corallo
No Relationships to Disclose
 
Sara Lonardi
Consulting or Advisory Role - Amgen; Bayer
Speakers' Bureau - Lilly; Roche
Research Funding - Sanofi
 
Chiara Cremolini
Consulting or Advisory Role - Amgen; Bayer; Roche
 
Lorenza Rimassa
Honoraria - Abbvie; AstraZeneca
Consulting or Advisory Role - Amgen; ArQule; Baxter; Bayer; Exelixis; Ipsen; Italfarmaco; Lilly; Sanofi; Sirtex Medical
Travel, Accommodations, Expenses - ArQule; Ipsen
 
Andrea Sartore-Bianchi
Consulting or Advisory Role - Amgen; Bayer; Roche
 
Marco Tampellini
No Relationships to Disclose
 
Sara Bustreo
No Relationships to Disclose
 
Matteo Clavarezza
No Relationships to Disclose
 
Roberto Murialdo
No Relationships to Disclose
 
Alberto Zaniboni
No Relationships to Disclose
 
Vincenzo Adamo
No Relationships to Disclose
 
Gianluca Tomasello
No Relationships to Disclose
 
Monica Giordano
No Relationships to Disclose
 
Fausto Petrelli
No Relationships to Disclose
 
Raffaella Longarini
No Relationships to Disclose
 
Vittorina Zagonel
No Relationships to Disclose
 
Maria Di Bartolomeo
Consulting or Advisory Role - Amgen; Lilly; Roche
 
Filippo G. De Braud
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Dompè; Ignyta; Novartis; Pfizer; SERVIER; Tiziana Life Sciences
Speakers' Bureau - Bristol-Myers Squibb; Lilly; Menarini; MSD; Novartis; Pfizer; Roche; SERVIER
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Ignyta (Inst); Lilly (Inst); MedImmune (Inst); Merck Serono (Inst); MSD (Inst); Nektar; Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Roche